Pilot Study: PARP1 Imaging in Advanced Prostate Cancer
ConclusionsFTT-PET/CT may serve as an alternate biomarker for PARP1 expression and a potential method for PARPi treatment selection.
Source: Molecular Imaging and Biology - Category: Molecular Biology Source Type: research
More News: Biology | Cancer | Cancer & Oncology | Gastroschisis Repair | Molecular Biology | Prostate Cancer | Study